Innovative Medicines Canada Statement on the PMPRB Regulations Announcement
Ottawa, April 20, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, issued the following statement in response to the Federal Government’s recent announcement on the […]
Innovative Medicines Canada Statement on Federal budget 2022
IMC is pleased with the ongoing commitments to increased access to innovative medicines and treatments […]
IMC welcomes renewed commitment to a pan-Canadian approach to pharmacare
IMC welcomes the federal government’s renewed commitment to enhancing access […]
War in Ukraine
IMC is saddened and dismayed by Russia’s unprovoked invasion of Ukraine. […]
Hope is Hard Work.
Our members have never shied away from doing whatever it takes — because it is worth it to provide hope to people when they need it most.
Medicines
New medicines and vaccines save lives and help make our healthcare system more cost‑effective.

Ethics
Setting a high standard for ethical, transparent, and open practices.

Innovation
Innovation has a large role to play in the sustainability of our healthcare system.

Posted June 17, 2022
WTO Decision on Waiving Intellectual Property Rights is the Wrong Solution to Address Barriers to Vaccine Equity

WTO Decision on Waiving Intellectual Property Rights is the Wrong Solution to Address Barriers to Vaccine Equity
Posted June 17, 2022
Ottawa, June 17, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, is disappointed by the intellectual property (IP) waiver to the Agreement on Trade-Related Aspects […]

Health Research Foundation
Canada’s Health Research Foundation invests in health innovation in Canada.